These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 10636259

  • 1. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB.
    J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
    [Abstract] [Full Text] [Related]

  • 2. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT.
    Circulation; 2002 Mar 19; 105(11):1348-53. PubMed ID: 11901047
    [Abstract] [Full Text] [Related]

  • 3. A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
    Jackson EK, Kost CK, Herzer WA, Smits GJ, Tofovic SP.
    J Pharmacol Exp Ther; 2001 Dec 19; 299(3):978-87. PubMed ID: 11714886
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC.
    Am J Physiol Renal Physiol; 2003 May 19; 284(5):F1115-9. PubMed ID: 12676739
    [Abstract] [Full Text] [Related]

  • 5. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 19; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC.
    Circulation; 2004 Apr 06; 109(13):1680-5. PubMed ID: 15023890
    [Abstract] [Full Text] [Related]

  • 7. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S.
    J Card Fail; 2007 Oct 06; 13(8):609-17. PubMed ID: 17923351
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC.
    Am J Physiol Renal Physiol; 2006 Feb 06; 290(2):F273-8. PubMed ID: 16189291
    [Abstract] [Full Text] [Related]

  • 9. Effects of adenosine receptor subtype A1 on ventricular and renal function.
    Lucas DG, Patterson T, Hendrick JW, Holder J, Sample JA, Joffs C, Davis J, Goldberg A, Mukherjee R, Smits GJ, Spinale FG.
    J Cardiovasc Pharmacol; 2001 Oct 06; 38(4):618-24. PubMed ID: 11588532
    [Abstract] [Full Text] [Related]

  • 10. Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.
    Vargo DL, Brater DC, Rudy DW, Swan SK.
    J Am Soc Nephrol; 1996 Jul 06; 7(7):1032-7. PubMed ID: 8829118
    [Abstract] [Full Text] [Related]

  • 11. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG, Merz E, Brooks DP.
    Br J Pharmacol; 2003 Aug 06; 139(8):1383-8. PubMed ID: 12922924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G.
    Eur J Heart Fail; 2000 Sep 06; 2(3):305-13. PubMed ID: 10938493
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study.
    Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):600-6. PubMed ID: 17692744
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.